T cell homeostatic proliferation elicits effective antitumor autoimmunity
about
Focus on adoptive T cell transfer trials in melanomaRemoval of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsCD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.Adoptive cell transfer: a clinical path to effective cancer immunotherapyChimeric antigen receptor therapy for cancerT-cell receptor gene therapy--ready to go viral?Harnessing the Microbiome to Enhance Cancer ImmunotherapyLearning and memory ... and the immune system.Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinityIn vivo imaging of T cell delivery to tumors after adoptive transfer therapy.Quantitative monitoring of mouse lung tumors by magnetic resonance imaging.Enhanced lymphocyte proliferation responses in pediatric patients early after myelosuppressive chemotherapy.Targeting macrophage anti-tumor activity to suppress melanoma progression.Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.History and current state of immunotherapy in glioma and brain metastasis.IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditionsThe allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Homeostatic proliferation is a barrier to transplantation tolerance.In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hostsPeripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.Memory-like CD8+ T cells generated during homeostatic proliferation defer to antigen-experienced memory cells.Biology and clinical effects of natural killer cells in allogeneic transplantation.Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types.Principles of adoptive T cell cancer therapy.Heterologous immunity between virusesSystemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.Type 1 interferons and antiviral CD8 T-cell responses.Control of homeostatic proliferation by regulatory T cells.Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotIL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals.Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.Making room for T cellsTherapeutic cancer vaccines: are we there yet?A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity
P2860
Q21328679-C7377479-3C38-42C5-9C58-A14C9EAB54C1Q24540135-4FE91617-7D8C-4932-A12E-0AAA256F9D3FQ24540429-A0EFE57C-C0A7-44DD-8C9F-B35EB2FEEEAFQ24644774-70B04BBE-2615-404B-8684-D07CD96BE3C9Q27013599-E5A37E46-A980-4059-9C76-FCD39A376309Q28081611-F848E048-0061-4489-B789-D652A343CF4AQ28088598-F0400871-8931-48E9-ABE9-4A8269236ED2Q30410489-4FC31A7F-115C-481D-BDE5-6DBF2620D1EDQ30413827-08F71EAF-E109-4B93-85F8-AE343DB0BFABQ30479855-B73CA447-333C-46ED-9051-3A4804757FBAQ30560325-DD635BCB-9D75-4271-AEB6-6859B5F99699Q33207177-947AE709-D138-4AC2-B9C7-83284E67F1ACQ33566997-4B67D4E4-F385-4BCD-8244-23A3DBD379EEQ33585305-F7D14A8E-49F9-4187-B55F-4155694804B1Q33656811-BA8041EF-91B5-40A0-A3CB-145E59D0A46EQ33697777-30BB219A-B625-4A6F-BC4A-B62AE0E3B7E3Q33724352-62CF3C28-C8EB-4119-A5D7-2FB588214A85Q33731951-B5886D42-2E79-4A3E-B73E-2E41755EC3E1Q33756565-45E5FE86-1AF8-43C4-B710-53E67EA9B303Q33760403-8A534F3E-AEC8-498C-A329-604C414040ACQ33772479-15F3061F-A2EF-4097-9B89-78DBD83AA21AQ33801059-1B0C8628-F758-4D78-856E-AC2986CD01D4Q33835506-E32710C3-042A-444E-A7D3-244812B3A994Q33893173-55B53825-4CE0-47D2-8366-8DAC974B5891Q33942539-ADF05623-C119-45D0-84DD-995B26359C6DQ34003932-1925B49B-CA0B-45C3-A1C2-8709CB3FDC27Q34051846-A97926A4-AA78-45A7-976C-5A91FF6A88F0Q34079316-B0DE25AE-BF68-463B-8F93-3139A8E5CB93Q34126296-54697970-F21E-46A7-BCA9-949D6ABB019CQ34133590-A86AA0BE-7871-46F8-924D-D3C11B629C3EQ34180369-8A648D4D-F944-404C-B260-79CEBB84C884Q34289372-A64CD969-2F6F-4190-A12B-3465A071A077Q34302103-C9D5A962-FA2D-4A58-A9E1-94FEB5E3372BQ34422330-01A97EE1-3981-4506-9675-E18BE104E9D3Q34426965-C68944E2-DDD0-4CFB-BD4B-E4943773FE57Q34634616-49AD4512-CB64-4C62-950B-56B391B91CF1Q34722415-D327F360-DD13-4F45-8A18-F5DD7353601AQ34744971-3858DF1E-A7CA-48B6-A103-7F5362F9A676Q34786691-31A141A3-9C29-409F-A1EC-8EA8AB648B5AQ34876814-FA0DCFE1-2002-4F99-A7CE-7221472DD66B
P2860
T cell homeostatic proliferation elicits effective antitumor autoimmunity
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@ast
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@en
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@nl
type
label
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@ast
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@en
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@nl
prefLabel
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@ast
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@en
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@nl
P2093
P2860
P3181
P1476
T cell homeostatic proliferation elicits effective antitumor autoimmunity
@en
P2093
Andreas G Niethammer
Argyrios N Theofilopoulos
Brian R Lawson
Norbert Wagner
Ralph A Reisfeld
Roberto Baccala
Wolfgang Dummer
P2860
P304
P3181
P356
10.1172/JCI0215175
10.1172/JCI15175
P407
P577
2002-07-01T00:00:00Z